MedTrace Logo

DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device

NCT05543447 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2025-09-04

No results posted yet for this study

Summary

To analyse the clinical safety and efficacy of the DERIVO® 2heal® Embolisation Device in the standard clinical routine of flow diversion treatment with respect to the mid- and long-term clinical and angiographic outcomes.

Conditions

  • Intracranial Aneurysm
  • Flow Diverter

Interventions

DEVICE

Flow Diverter Treatment with DERIVO 2 Heal Embolisation Device

Flow diversion therapy fpr intracranial aneurysm treatment.

Sponsors & Collaborators

  • Acandis GmbH

    lead INDUSTRY

Principal Investigators

  • Behme Daniel, Prof. · Universitätsklinikum Magdeburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543447 on ClinicalTrials.gov